The interface of COVID-19, diabetes, and depression

Steenblock, Charlotte; Schwarz, Peter E. H.; Perakakis, Nikolaos; Brajshori, Naime; Beqiri, Petrit; Bornstein, Stefan R.

doi:10.1007/s44192-022-00007-0

Cited by 12 publications

(10 citation statements)

References 82 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The COVID-19 pandemic also affects mental health because of lockdown and quarantine measurements 86 87 . Diabetes has been connected to an increased risk of depression 88 89 90 91 , and equally, people with depression exhibit a more than 30% higher risk of developing diabetes than people without depression 92 93 .…”

Section: Introductionmentioning

confidence: 99%

Diabetes and COVID-19: Short- and Long-Term Consequences

et al. 2022

Self Cite

View full text Add to dashboard Cite

When the corona pandemic commenced more than two years ago, it was quickly recognized that people with metabolic diseases show an augmented risk of severe COVID-19 and an increased mortality compared to people without these comorbidities. Furthermore, an infection with SARS-CoV-2 has been shown to lead to an aggravation of metabolic diseases and in single cases to new-onset metabolic disorders. In addition to the increased risk for people with diabetes in the acute phase of COVID-19, this patient group also seems to be more often affected by long-COVID and to experience more long-term consequences than people without diabetes. The mechanisms behind these discrepancies between people with and without diabetes in relation to COVID-19 are not completely understood yet and will require further research and follow-up studies during the following years. In the current review, we discuss why patients with diabetes have this higher risk of developing severe COVID-19 symptoms not only in the acute phase of the disease but also in relation to long-COVID, vaccine breakthrough infections and re-infections. Furthermore, we discuss the effects of lockdown on glycemic control.

show abstract

Section: Introductionmentioning

confidence: 99%

Diabetes and COVID-19: Short- and Long-Term Consequences

et al. 2022

Self Cite

View full text Add to dashboard Cite

show abstract

“…Due to its resemblance with Long/Post COVID, a common etiopathogenesis has been suggested [17,18]. Unexplainable postacute infection syndrome (PAIS) is not unique to SARS-CoV-2 infections, but has been reported for all kinds of infectious agents, including bacteria, viruses, and parasites For example, PAIS has been reported for a number of viruses, such as Epstein-Barr (EBV), Ebola, Dengue, polio, SARS-CoV-1, Chikungunya, West Nile, Ross River, and enteroviruses [4].…”

Section: Post-infection Chronic Fatigue Syndromementioning

confidence: 99%

Post COVID and Apheresis – Where are we Standing?

et al. 2022

Self Cite

View full text Add to dashboard Cite

A continual increase in cases of Long Covid constitutes a medical and socioeconomic challenge to health systems around the globe. While the true extent of this problem cannot yet be fully evaluated, recent data suggests that up to 20% of people with confirmed with SARS-CoV-2 suffer from clinically relevant symptoms of Long Covid several weeks to months after the acute phase. The clinical presentation is highly variable with the main symptoms being chronic fatigue, dyspnea and cognitive symptoms. Extracorporeal apheresis has been suggested to alleviate symptoms of Long Covid. Thus, numerous patients are currently treated with apheresis. However, at present there is no data from randomized controlled trials available to confirm the efficacy. Therefore, physicians rely on the experience of practitioners and centers performing this treatment. Here, we summarize clinical experience on extracorporeal apheresis in patients with Long Covid from centers across Germany.

show abstract

“…To our knowledge, limited studies have determined the depressive symptoms, anxiety symptoms, and stress among home isolated patients infected with COVID-19 in Nepal. Understanding the association between depressive, anxiety, and stress-related symptoms with the presence of COVID-19 symptoms and comorbid status among home isolated COVID-19 patients provides a concrete basis for tailoring and implementing relevant mental health intervention policies [ 19 ] to reduce their burden in Nepal.…”

Section: Introductionmentioning

confidence: 99%